Magnesium supplementation reduces plasma C-reactive protein (CRP) concentrations in those with levels > 3 mg/dL, which is indicative of inflammation and an increased risk for cardiovascular disease [137]. The gene discussed is CRP; the disease is cardiovascular disorder.